SSRI

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

October 7, 2012 |
burger_pills.jpg

Part II.  What Do We Get for All That Money?  A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic;  Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;

Continue reading →

Safety Issues: FDA Scientists Collide with FDA Managers

September 14, 2012 |

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.

Continue reading →

FDA Scientists Collide with FDA Managers Re: Safety Issues

September 8, 2012 |

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →

Vicissitudes of Psychiatry’s Diagnostic Manual Revisions

May 14, 2012 |

The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling.  It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars. Continue reading →

Psychiatry Texbook Penned by Two Academic Leaders –GSK Ghosted

November 30, 2010 |

“To ghostwrite an entire textbook is a new level of chutzpah,” said Dr. David A. Kessler, former commissioner of the Food and Drug Administration, after reviewing the documents. “I’ve never heard of that before. It takes your breath away.” Continue reading →